Any Need for Preoperative Cardiac Testing in Intermediate-Risk Patients With Tight Beta-Adrenergic Blockade?* * Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 48, Issue 5, 2006, Pages 970-972

  Eagle, Kim A ^a   Lau, Wei C ^a  

^a Division of Cardiovascular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; EDITORIAL; HEART DEATH; HEART INFARCTION; HEART PROTECTION; HEART RATE; HUMAN; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL RISK; VASCULAR SURGERY;

ADRENERGIC BETA-ANTAGONISTS; CORONARY ARTERIOSCLEROSIS; EXERCISE TEST; HEART RATE; HUMANS; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; RISK ASSESSMENT;

EID: 33748177895     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.06.008     Document Type: Editorial

References (21)

1. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 39 (2002) 542-553
2. Wesorick D.H., and Eagle K.A. The preoperative cardiovascular evaluation of the intermediate-risk patient. new data, changing strategies. Am J Med 118 (2005) 1413
3. Boersma E., Poldermans D., Bax J.J., et al. Predictors of cardiac events after major vascular surgery. role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285 (2001) 1865-1873
4. Lindenauer P.K., Pekow P., Wang K., et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 (2005) 349-361
5. Auerbach A.D., and Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery. clinical applications. JAMA 287 (2002) 1445-1447
6. Poldermans D., Bax J.J., Schouten O., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 (2006) 964-969
7. Yusuf S., Collins R., and Peto R. Why do we need some large, simple randomized trials?. Stat Med 3 (1984) 409-422
8. McFalls E.O., Ward H.B., Moritz T.E., et al. Coronary artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
9. Mangano D.T., Layug E.L., Wallace A., et al., Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 335 (1996) 1713-1720
10. Poldermans D., Boersma E., Bax J.J., et al., Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341 (1999) 1789-1794
11. Devereaux P.J., Beattie W.S., Choi P.T., et al. How strong is the evidence for the use of perioperative (beta) blockers in non-cardiac surgery? Systematic review and meta-analysis of randomized controlled trials. BMJ 331 (2005) 313-321
12. Brady A.R., Gibbs J.S., Greenhalgh R.M., et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery. results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
13. Devereaux P.J., Leslie K., and Yang H. The effect of perioperative beta-blockers on patients undergoing noncardiac surgery-is the answer in?. Can J Anaesth 51 (2004) 749-755
14. Stevens R.D., Burri H., and Tramer M.R. Pharmacologic myocardial protection in patients undergoing noncardiac surgery. a quantitative systematic review. Anesth Analg 97 (2003) 623-633
15. Raby K.E., Brull S.J., Timimi F., et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88 (1999) 477-482
16. Cruickshank J.M. Beta-blockers continue to surprise us. Eur Heart J 21 (2000) 354-364
17. Yeager M.P., Fillinger M.P., Hettleman B.D., et al. Perioperative beta-blockade and late cardiac outcomes. a complementary hypothesis. J Cardiothorac Vasc Anesth 19 (2005) 237-241
18. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2006 guideline update for perioperative cardiovascular evaluation for noncardiac surgery. focused update on perioperative beta-blocker therapy-a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 47 (2006) 2343-2355
19. Kertai M.D., Boersma E., Westerhout C.M., et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 28 (2004) 343-352
20. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
21. Durazzo A.E., Machado F.S., Ikeoka D.T., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin. a randomized trial. J Vasc Surg 39 (2004) 967-975 discussion 975-66